Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Energy Fuels Inc Ordinary Shares (Canada) (UUUU) Price & Performance

Heron Therapeutics IncTrade
Energy Fuels Inc Ordinary Shares (Canada)Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Energy Fuels Inc Ordinary Shares (Canada) — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $74.18M), while Energy Fuels Inc Ordinary Shares (Canada) trades at $8.29 (market cap $2.45B). The key difference: Energy Fuels Inc Ordinary Shares (Canada) is far larger — about 33× Heron Therapeutics Inc's market cap, and Energy Fuels Inc Ordinary Shares (Canada) is more actively traded (7,967,898 versus 1,857,401). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 36 Days and Energy Fuels Inc Ordinary Shares (Canada) for 0 Days on average.

HRTXUUUU
Market Cap
$74.18M$2.45B
Volume
1,857,4017,967,898
Sector
HealthEnergy
52-Week High
$1.49$27.72
52-Week Low
$0.27$8.34
Typical Hold Time
36 Days0 Days
Enterprise Value
$180.92M$2.19B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3906, down 6.02% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates. Despite a high gross margin of 70.07%, it posted a net loss of -$20.20 million in 2025. Analyst consensus is strongly positive with 17 buy ratings. Recent news highlights earnings results and competitive comparisons.

The outlook remains speculative given persistent losses and negative ROE, but strong analyst support and improving cash flow trends offer potential upside. Key risks include profitability challenges and revenue volatility. Investors should weigh the bullish sentiment against fundamental weaknesses.

Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels (UUUU) trades at $9.27, down 4.04% amid negative sentiment following a securities fraud investigation announcement. The stock shows weak technical positioning near recent lows with neutral indicators. Fundamentally, the company continues to report significant losses with a -77.3% net income margin despite revenue growth projections, while heavy investment in uranium and rare earth expansion creates substantial cash burn.

While analyst consensus remains bullish with a $21.06 price target representing 127% upside, execution risks are elevated. The securities investigation, persistent losses, and massive capital requirements for growth projects create substantial headwinds. Success depends on the company's ability to fund expansion and achieve profitability in the competitive critical minerals sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
67% Buy33% Sell
Avg holding period · 36 Days
UUUU
69% Buy31% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Energy Fuels Inc Ordinary Shares (Canada)

Energy Fuels Inc. is a US producer of uranium, vanadium, and rare earth elements. It operates the White Mesa Mill in Utah, the only fully licensed and operating conventional uranium processing facility in the country.

Read more on UUUU →